This website uses cookies. The website, owned by Alantra Partners, S.A., uses private and third-party cookies in order to allow and optimize your browsing, by analyzing your habits when using the website. For more information visit our Cookie policy.
Accept
Search

What we do / Investment Banking / Transactions / Alantra advised Lydall on the sale of Charter Medical

Alantra advised Lydall on the sale of Charter Medical

SECTORHealthcare; Industrials

ServiceM&A

Value $29.9 million

Jan 2015
Sell-side advisory
Value $29.9 million

Alantra advised Lydall, Inc. (NYSE:LDL) on the sale of Charter Medical Ltd. to a US subsidiary of Fenner PLC (LSE:FENR), for $29.9 million

View Healthcare View The United States

Related Transactions

View All